HUMAN ANTIBODIES THAT BINDING LYMPHOCYTE ACTIVATION GENE-3 (LEG-3), AND USES THEREOF

CY1125618T1Undetermined Publication Date: 2026-04-17ER SQUIBB & SONS LLC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CY20221100674T
Authority / Receiving Office
CY · CY
Patent Type
Patents
Current Assignee / Owner
Priority Date
2008-08-11
Filing Date
2022-10-12
Publication Date
2026-04-17
Estimated Expiration
2042-10-12
Patent Text Reader

Abstract

The present disclosure provides isolated human monoclonal antibodies and antigen-binding fragments thereof that bind to human LAG-3, particularly antibodies and antigen-binding antibody fragments that can inhibit the binding of LAG-3 to MHC Class II molecules and that can stimulate antigen-specific T cell responses. Nucleic acid molecules encoding the antibodies and antigen-binding fragments of the invention as well as compositions and immunoconjugates of the antibodies and antigen-binding antibody fragments of the invention are also provided. This disclosure also provides for the use of the antibodies and antigen-binding antibody fragments of the invention in therapy.
Need to check novelty before this filing date? Find Prior Art